[Recent studies and acquisitions on microvascular lesions in diabetes mellitus].

G. Costanzi,A. Mancini,G. Zampa,G. Kelescian

1966-02-01

Abstract:

What problem does this paper attempt to address?

Delayed Sustained Drug Release from Electrostatic Powder Coated Tablets with Ultrafine Polymer Blends

Qingliang Yang,Feng Yuan,Jiale Chen,Hang Zhou,Gensheng Yang,Jesse Zhu

DOI: https://doi.org/10.1016/j.powtec.2021.08.088

IF: 4.969

2016-01-01

Advanced Powder Technology

Abstract:The present study aims to apply an electrostatic dry powder coating process to coat aspirin tablets with polymer blends to produce a single-layer coating film, which potentially allows an advantageous delayed sustained drug release profile. The coating formulations containing polymer blends of enteric polymer (hydroxypropyl methylcellulose phthalate or hydroxypropyl methyl cellulose acetate-succinate) and insoluble polymer (Eudragit® RL) were successfully developed and optimized. Results of scanning electron microscopy and acid resistance test demonstrated that curing conditions had a significant impact on the qualities of the produced film. Drug dissolution experiments revealed that changes in the coating level and the coating formulation with different ratios of the enteric polymer to the insoluble polymer achieved an altered and adjustable drug release profile. All of the results suggested that electrostatic powder coating technology is capable to produce a satisfactory coating film with polymer blends, allowing an advantageous functionality of delayed sustained drug release.
Polyvinyl Alcohol-Based 3D Printed Tablets: Novel Insight into the Influence of Polymer Particle Size on Filament Preparation and Drug Release Performance

Andrea Gabriela Crișan,Alina Porfire,Rita Ambrus,Gábor Katona,Lucia Maria Rus,Alin Sebastian Porav,Kinga Ilyés,Ioan Tomuță

DOI: https://doi.org/10.3390/ph14050418

IF: 4.6

2021-05-01

Pharmaceuticals

Abstract:Three-dimensional printing (3DP) by fused deposition modeling (FDM) has gained momentum as a promising pharmaceutical manufacturing method due to encouraging forward-looking perspectives in personalized medicine preparation. The current challenges the technology has for applicability in the fabrication of solid dosage forms include the limited range of suitable pharmaceutical grade thermoplastic materials. Hence, it is important to investigate the implications of variable properties of the polymeric carrier on the preparation steps and the final output, as versatile products could be obtained by using the same material. In this study, we highlighted the influence of polyvinyl alcohol (PVA) particle size on the residence time of the mixtures in the extruder during the drug-loaded filament preparation step and the consequent impact on drug release from the 3D printed dosage form. We enhanced filament printability by exploiting the plasticizing potential of the active pharmaceutical ingredient (API) and we explored a channeled tablet model as a design strategy for dissolution facilitating purposes. Our findings disclosed a new perspective regarding material considerations for the preparation of PVA-based solid dosage forms by coupling hot melt extrusion (HME) and FDM-3DP.

pharmacology & pharmacy,chemistry, medicinal
Study and Characterization of Polyvinyl Alcohol-Based Formulations for 3D Printlets Obtained via Fused Deposition Modeling

Sofiya Ilieva,Dilyana Georgieva,Valentina Petkova,Milen Dimitrov

DOI: https://doi.org/10.3390/pharmaceutics15071867

IF: 6.525

2023-07-02

Pharmaceutics

Abstract:Three-dimensional (3D) printing has emerged as a new promising technique for the production of personalized dosage forms and medical devices. Polyvinyl alcohol is prominently used as a source material to produce 3D-printed medicines via fused deposition modeling (FDM)—a technology that combines hot melt extrusion and 3D printing. A preliminary screening of three grades of PVA indicated that partially hydrolyzed PVA with a molecular weight (MW) of 31,000–50,000 and plasticized with sorbitol was most suitable for 3D printing. Paracetamol was used as a model drug. The materials and the produced filaments were characterized by X-ray powder diffraction (XRPD), thermogravimetric analysis (TGA), and differential scanning calorimetry (DSC). The complex viscosity (η*) of the polymer melts was determined as a function of the angular frequency (ω) at the printing temperature to assess their printability. Three-dimensional printlets with a 40% infill exhibited an immediate release of the API, while tablets with a higher infill were prone to a prolonged release regardless of the filament drug loading. A factorial design was used to give more insight into the influence of the drug-loading of the filaments and the tablet infill as independent variables on the production of 3D printlets. The Pareto chart confirmed that the infill had a statistically significant effect on the dissolution rate after 45 min, which was chosen as the response variable.

pharmacology & pharmacy
Dose-independent drug release from 3D printed oral medicines for patient-specific dosing to improve therapy safety

Hellen Windolf,Rebecca Chamberlain,Julian Quodbach

DOI: https://doi.org/10.1016/j.ijpharm.2022.121555

2022-03-25

Abstract:Fused deposition modelling (FDM) 3D printing provides the ability to address individual patients' therapeutic needs without having to change the formulation every time. This is particularly interesting for dosing and release modelling. In this study, a geometry model was developed that can represent variable dosages while keeping the surface area to volume (SA/V) ratio alike, so the drug release profiles remain similar. The model was tested on three different formulations. Two BCS I active pharmaceutical ingredients (API), pramipexole and levodopa, and one BCS II API, praziquantel, were used. Polyvinyl alcohol (PVA, water soluble) and a combination of vinylpyrrolidone-vinyl acetate copolymer (PVP-VA, water soluble) and ethylene-vinyl acetate (EVA, water insoluble) were used as the polymer matrix. The curves were compared using the similarity factor (f2 value) and mean dissolution time (MDT). Using a hollow cylinder-based (HCb) geometry model, a dose-independent drug release could be realized. For the PVA formulations, an 8-fold dose change could be obtained and for the EVA-PVP-VA formulation a factor of 5.5 could be achieved, with f2 > 50. Due to the layer structure of the printed objects, very fine dose variation of 0.13 mg per layer is possible within these models. This allows variable dosing in small steps with only one basis formulation.
Production of Bi-Compartmental Tablets by FDM 3D Printing for the Withdrawal of Diazepam

Joana Macedo,Rita Marques,Chris Vervaet,João F. Pinto

DOI: https://doi.org/10.3390/pharmaceutics15020538

IF: 6.525

2023-02-07

Pharmaceutics

Abstract:Diazepam (DZP) is a long-acting benzodiazepine to treat anxiety or acute alcohol withdrawal. Although this class of drugs should be taken for a short period of time, many patients take them for longer than recommended, which has been linked to an increased risk of dementia and dependence. The present work aimed at using the dual-nozzle system of fused deposition modeling (FDM) 3D printers to prepare tablets with gradual doses of DZP with constant mass and size. Placebo and DZP-loaded filaments were prepared by hot-melt extrusion and used to print the bi-compartmental tablets. Thermal processing allowed the conversion of crystalline DZP to its amorphous counterpart. Tablets with different DZP contents were effectively printed with a mass, thickness and diameter average of 111.6 mg, 3.1 mm, and 6.4 mm, respectively. Microscopic data showed good adhesion between the different layers in the printed tablets. The desired drug contents were successfully achieved and were within the acceptance criteria (European Pharmacopeia). The combination of a placebo and drug-loaded extrudates proved to be beneficial in the production of tablets by FDM for patients in need of drug withdrawal.

pharmacology & pharmacy
Unraveling the Influence of Solvent Composition on Drop-on-Demand Binder Jet 3D Printed Tablets Containing Calcium Sulfate Hemihydrate

Anqi Lu,Ishaan Duggal,Baher A Daihom,Yu Zhang,Mohammed Maniruzzaman,Baher A. Daihom

DOI: https://doi.org/10.1016/j.ijpharm.2023.123652

IF: 6.51

2023-12-01

International Journal of Pharmaceutics

Abstract:Recently, binder jet printed muscular tablets were loaded with three anti-viral drugs via Drop on Demand (DoD) technology where drug solutions prepared in ethanol showed faster release than those prepared in water. During printing, water is used as a binding agent, whereas ethanol is added to maintain the porous structure of the tablets. Thus, the hypothesis is that the porosity would be controlled by manipulating the percentage of water and ethanol. In this study, Rhodamine 6G (R6G) was selected as a model drug due to its high solubility in water and ethanol, visualization function as a fluorescent dye, and potential therapeutical effects for cancer treatment. Approximately, 10 mg/ml R6G solutions were prepared with five different water-ethanol ratios (0-100, 75-25, 50-50, 75-25, 100-0). The ink solutions were printed onto blank binder jet 3D-printed tablets containing calcium sulphate hemihydrate using DoD technology. The tablets were dried at room temperature and then characterized using SEM-EDX, fluorescent microscope, TGA, XRD, FTIR, and DSC as well as in vitro release studies to investigate the impact of the water-ethanol ratio on the release profile of R6G. Results indicated that the solution with higher ethanol ratio penetrated the tablets faster than the lower ethanol ratio. That solution prepared with pure water was first accumulated onto the tablets' surface and then absorbed by the tablets. Moreover, tablets with more water content gained more weight and thickness. The EDX and fluorescent microscope showed the uniform surface distribution of the drug. The SEM images revealed the difference in the tablet surface among the five formulations. Furthermore, the TGA data presents a notable increase in water loss, with XRD analysis suggesting the formation of gypsum in tablets containing elevated water content. The release study exhibited that the fastest release was from WE0-100, whereas the release rate decreases as the content of water increases. The WE0-100 releases more than 40% drug within the first hour which is almost twice as high of the WE100-0 formulation. This DoD technology could distribute drugs onto the tablet's surface uniformly. The calcium sulfate would transform from hemihydrate to dihydrate form while adding water. The tablets treated with higher water content led to slower release. In conclusion, this study underscores the substantial impact of the water-ethanol ratio on drug release from binder jet printed tablets and highlights the potential of DoD technology for uniform drug distribution and controlled release.

pharmacology & pharmacy
Digital light processing (DLP) 3D printing technique applied in the fabrication of two-layered tablets: The concept of a combined polypill

Ivana Adamov,Đorđe Medarević,Branka Ivković,Aleksandar Ivković,Svetlana Ibrić

DOI: https://doi.org/10.5937/arhfarm72-40365

2022-01-01

Arhiv za farmaciju

Abstract:Ever since 3D printing was introduced to the field of pharmacy, it has caused a paradigm shift from the manufacturing of large-scale to small batches of medicines tailored accordingly to the specific needs of patients. This study aimed to formulate and fabricate two-layered 3D tablets using the digital light processing (DLP) technique. Hydrochlorothiazide (HHT,5%,w/w) and warfarin sodium (WS,5%,w/w) were selected as model drugs. The printing process was initiated with 0.1% of photoinitiator, at a constant ratio of poly(ethylene glycol)diacrylate and poly(ethylene glycol) 400, 1:1, with the addition of water (10%,w/w). Single-layered tablets of 8.00 mm diameter and 1.50 mm thickness, containing HHT and WS respectively, were successfully printed, as well as combined two-layered 3D tablets, with each of the active substances in separate layers. Dissolution tests of single-layered tablets showed immediate, but incomplete release of WS (81.47±1.47%, after 45min), and prolonged and complete release of HHT (98.17±3.11%, after 8h), while significantly slower and incomplete release of both drugs from the combined two-layered 3D tablets was observed. The absence of drug-polymer interaction and presence of a layered cross-sectional tablet structure were confirmed. DLP technique enables simple and rapid fabrication of combined two-layered 3D tablets, while further optimization of formulation factors is necessary to achieve complete drug release.
Impact of immediate release film coating on the disintegration process of tablets

Mingrui Ma,Daniel Powell,Marwa Nassar,Jason Teckoe,Daniel Markl,J Axel Zeitler

DOI: https://doi.org/10.1016/j.jconrel.2024.07.037

2024-07-27

Abstract:Pharmaceutical tablets are often coated with a layer of polymeric material to protect the drug from environmental degradation, facilitate the packaging process, and enhance patient compliance. However, the detailed effects of such coating layers on drug release are not well understood. To investigate this, flat-faced pure microcrystalline cellulose tablets with a diameter of 13 mm and a thickness between 1.5 mm to 1.6 mm were directly compressed, and a film coating layer with a thickness of 80 μm to 120 μm was applied to one face of these tablets. This tablet geometry and immediate release film coating were chosen as a model system to understand how the film coating interacts with the tablet core. The coating hydration and dissolution process was studied using terahertz pulsed imaging, while optical coherence tomography was used to capture further details on the swelling process of the polymer in the coated tablet. The study investigated the film coating polymer dissolution process and found the gelling of dissolving polymer restricted the capillary liquid transport in the core. These findings can help predict the dissolution of film coating within the typical range of thickness (30 μm to 40 μm) and potentially be extended to understand modified release coating formulations.
Dosage by design - 3D printing individualized cabozantinib tablets with immediate release

Jonas Lenhart,Dominique J Lunter

DOI: https://doi.org/10.1016/j.ejpb.2024.114501

Abstract:Production of patient-specific dosage forms is important to improve patient adherence and effectiveness while reducing the prevalence and severity of adverse effects. Due to its possibility of rapid prototyping 3D printing can be used to produce individual dosages while utilizing techniques such as hot melt extrusion to increase the bioavailability of poorly soluble drugs. In this work, Parteck MXP and Kollicoat IR were used as water-soluble polymer bases for formulation development for 3D printing of various dosages incorporating cabozantinib while enabling immediate release. The effect of tablet design and the excipients sorbitol, croscarmellose sodium, and sodium starch glycolate was investigated for this goal. A way to calculate the size of tablets for predetermined dosages is proposed to enable the printing of individual strengths from one formulation. Rheological data were collected to deepen the understanding of the role of melt viscosity in 3D printing and hot melt extrusion processes. The production of immediate-release cabozantinib tablets containing every therapeutically relevant dosage in a single unit produced by two-step 3D printing was realized.
Novel On-Demand 3-Dimensional (3-D) Printed Tablets Using Fill Density as an Effective Release-Controlling Tool

Rishi Thakkar,Amit Raviraj Pillai,Jiaxiang Zhang,Yu Zhang,Vineet Kulkarni,Mohammed Maniruzzaman

DOI: https://doi.org/10.3390/polym12091872

IF: 5

2020-08-20

Polymers

Abstract:This research demonstrates the use of fill density as an effective tool for controlling the drug release without changing the formulation composition. The merger of hot-melt extrusion (HME) with fused deposition modeling (FDM)-based 3-dimensional (3-D) printing processes over the last decade has directed pharmaceutical research towards the possibility of printing personalized medication. One key aspect of printing patient-specific dosage forms is controlling the release dynamics based on the patient’s needs. The purpose of this research was to understand the impact of fill density and interrelate it with the release of a poorly water-soluble, weakly acidic, active pharmaceutical ingredient (API) from a hydroxypropyl methylcellulose acetate succinate (HPMC-AS) matrix, both mathematically and experimentally. Amorphous solid dispersions (ASDs) of ibuprofen with three grades of AquaSolveTM HPMC-AS (HG, MG, and LG) were developed using an HME process and evaluated using solid-state characterization techniques. Differential scanning calorimetry (DSC), powder X-ray diffraction (pXRD), and polarized light microscopy (PLM) confirmed the amorphous state of the drug in both polymeric filaments and 3D printed tablets. The suitability of the manufactured filaments for FDM processes was investigated using texture analysis (TA) which showed robust mechanical properties of the developed filament compositions. Using FDM, tablets with different fill densities (20–80%) and identical dimensions were printed for each polymer. In vitro pH shift dissolution studies revealed that the fill density has a significant impact (F(11, 24) = 15,271.147, p −0.99; p < 0.0001) with the release performance, where 20% infill demonstrated the fastest and most complete release, whereas 80% infill depicted a more controlled release. The results obtained from this research can be used to develop a robust formulation strategy to control the drug release from 3D printed dosage forms as a function of fill density.

polymer science
Influence of Polymer Film Thickness on Drug Release from Fluidized Bed Coated Pellets and Intended Process and Product Control

Marcel Langner,Florian Priese,Bertram Wolf

DOI: https://doi.org/10.3390/pharmaceutics16101307

IF: 6.525

2024-10-09

Pharmaceutics

Abstract:Background/Objectives: Coated drug pellets enjoy widespread use in hard gelatine capsules. In heterogeneous pellets, the drug substance is layered onto core pellets. Coatings are often applied to generate a retarded release or an enteric coating. Methods: In the present study, the thickness of a polymer coating layer on drug pellets was correlated to the drug release kinetics. Results: The question should be answered whether it is possible to stop the coating process when a layer thickness referring to an intended drug release is achieved. Inert pellets were first coated with sodium benzoate and second with different amounts of water insoluble polyacrylate in a fluidized bed apparatus equipped with a Wurster inlet. The whole process was controlled in-line and at-line with process analytical technology by the measurement of the particle size and the layer thickness. The in-vitro sodium benzoate release was investigated, and the data were linearized by different standard models and compared with the polyacrylate layer thickness. With increasing polyacrylate layer thickness the release rate diminishes. The superposition of several processes influencing the release results in release profiles corresponding approximately to first order kinetics. The coating layer thickness corresponds to a determined drug release profile. Conclusions: The manufacturing of coated drug pellets with intended drug release is possible by coating process control and layer thickness measurement. Preliminary investigations are necessary for different formulations.

pharmacology & pharmacy
Development of FDM 3D-printed tablets with rapid drug release, high drug-polymer miscibility and reduced printing temperature by applying the acid-base supersolubilization (ABS) principle

Nirali G Patel,Abu T M Serajuddin

DOI: https://doi.org/10.1016/j.ijpharm.2021.120524

2021-05-01

Abstract:Some of the major issues with the development of FDM 3D printed tablets are slow drug release, lack of drug-polymer miscibility, high processing temperature, and poor printability. In this investigation, these issues were addressed by using a novel physicochemical principle called acid-base supersolubilization (ABS) previously developed in our laboratory. The aqueous solubility of a basic drug, haloperidol, was increased to ~300 mg/g of solution by adding glutaric acid, and, upon drying, the concentrated solutions produced amorphous materials. Similar amorphous systems could also be produced by heating haloperidol-glutaric acid mixtures. Filaments for 3D printing were prepared by melt extrusion of formulations containing 15% w/w haloperidol and 10.5% glutaric acid (1:2 M ratio) along with 74.5% polymers, such as Kollidon® VA64 alone or its mixtures with Affinisol™ 15cP. Filaments could be extruded and printed at low temperatures of 115 and 120 °C, respectively. Haloperidol was fully miscible in the formulations because of the acid-base interaction and formed amorphous systems even at higher drug loads. Although filaments of haloperidol-Kollidon® VA64 mixtures by themselves cannot be printed, the printability of formulation improved such that those containing glutaric acid were printable. Drug release rates from the formulations at pH 2 and 6.8 were rapid and complete.
Evaluation of Printability of PVA-Based Tablets from Powder and Assessment of Critical Rheological Parameters

Jonas Lenhart,Florian Pöstges,Karl G. Wagner,Dominique J. Lunter

DOI: https://doi.org/10.3390/pharmaceutics16040553

IF: 6.525

2024-04-20

Pharmaceutics

Abstract:Fused deposition modeling (FDM) is a rather new technology in the production of personalized dosage forms. The melting and printing of polymer–active pharmaceutical ingredient (API)—mixtures can be used to produce oral dosage forms with different dosage as well as release behavior. This process is utilized to increase the bioavailability of pharmaceutically relevant active ingredients that are poorly soluble in physiological medium by transforming them into solid amorphous dispersions (ASD). The release from such ASDs is expected to be faster and higher compared to the raw materials and thus enhance bioavailability. Printing directly from powder while forming ASDs from loperamide in Polyvinylalcohol was realized. Different techniques such as a change in infill and the incorporation of sorbitol as a plastisizer to change release patterns as well as a non-destructive way for the determination of API distribution were shown. By measuring the melt viscosities of the mixtures printed, a rheological model for the printer used is proposed.

pharmacology & pharmacy
The Use of 3D Printed Molds to Cast Tablets with a Designed Disintegration Profile

Adil Ajmal,Ammon Meskarzadeh,Natalja Genina,Cosima Hirschberg,Johan Peter Boetker,Jukka Rantanen

DOI: https://doi.org/10.1208/s12249-019-1341-z

IF: 3.3

2019-02-26

AAPS PharmSciTech

Abstract:Development of new product design principles is crucial for obtaining pharmaceutical products with controlled functionality. Four different molds were designed using a computer-aided design (CAD) software and 3D printed with polylactic acid (PLA). A hydroxypropyl methylcellulose (HPMC) and polyethylene glycol (PEG)-based formulation containing indomethacin as the active pharmaceutical ingredient (API) was casted into the molds. Each mold produced a tablet that was designed to disintegrate into a defined number of sections (2, 4, and 6). This was achieved by incorporating break lines (regions that were significantly thinner than the remainder of the tablet) to control the disintegration process. Disintegration and drug release from these designed tablets was contrasted with a casted tablet without break lines. Disintegration studies confirmed that the casted tablets disintegrated according to their design. Drug-release studies meanwhile demonstrated that tablets with a greater number of sections released the API at a faster rate than those with fewer sections; for example, the 6-sectioned tablet released the API at twice the rate of the tablet without any break lines. It is expected that by using this concept, it would be possible to produce tablets with a designed disintegration profile, which could potentially allow the tailoring of the drug release.
Fused deposition modeling 3D printing of solid oral dosage forms containing amorphous solid dispersions: How to elucidate drug dissolution mechanisms through surface spectral analysis techniques?

Chloé Parulski,Eva Gresse,Olivier Jennotte,Alexandre Felten,Eric Ziemons,Anna Lechanteur,Brigitte Evrard

DOI: https://doi.org/10.1016/j.ijpharm.2022.122157

IF: 6.51

2022-10-15

International Journal of Pharmaceutics

Abstract:Many active principles belong to the second class of the Biopharmaceutics Classification System due to their low aqueous solubility. Elaboration of new solid oral forms by hot-melt extrusion and fused deposition modeling appears as a promising tool to increase the dissolution rate of these drugs. Indeed, hot-melt extrusion allows the amorphisation of drugs and forms with complex geometries are built by 3D printing. Therefore, the goal of this work is to enhance the dissolution rate of poorly soluble drugs using hot-melt extrusion coupled with fused deposition modeling.Four formulations containing Affinisol® 15LV, Kollidon® VA64 and a challenging amount of itraconazole (25 % (wt.)) were successfully printed into forms of 20, 50 and 80 % infill densities. Differential scanning calorimetry analysis has shown that itraconazole remained amorphous during 52 weeks. The drug release rate was highly improved compared to itraconazole in a crystalline form. The dissolution rate was influenced by the infill density and the polymer composition of printed forms which could modify respectively the surface to volume ratio and the distribution of the components in the printed forms. One formulation printed with 20 % infill density even had a solubility profile similar to that of Sporanox®, the commercialized drug product in Belgium.

pharmacology & pharmacy
Application of PDMS-based coating in drug delivery systems using PVP as channeling agent

Hanie Soroory,Arezou Mashak,Azam Rahimi

DOI: https://doi.org/10.1007/s13726-013-0178-7

IF: 2.485

2013-08-20

Iranian Polymer Journal

Abstract:PDMS derivatives have been extensively used as coating in controlled drug delivery systems in pharmaceutical area. The major advantages of these materials are facilitation of adjustment of desired drug release patterns, improvement of film formation and storage stability. In this study PDMS-based coating systems were designed and applied to acetaminophen tablets and their release was investigated from the PDMS-coated tablet dosage form as a drug model. Thus, a water emulsion of PDMS containing tetraethoxysilane as cross-linking agent and polyvinylpyrrolidone (PVP) as channeling agent was prepared. Then, a uniform smooth thin coating of PDMS was applied on acetaminophen tablets and in vitro acetaminophen release from PDMS-coated tablets was carried out with a homemade setup. The morphology of the coated surfaces was studied by SEM technique. The effect of PVP on the mechanical properties of PDMS film was investigated by dynamic mechanical analysis. It was found that, PVP increased the mechanical properties of PDMS. Compounding of polyethylene glycol (PEG) with PVP (1:1) as channeling agents was also studied and compared with PVPs-containing samples. Despite more channeling agent content in PEG–PVP samples, the drug release percentage was decreased.

polymer science
Enzyme immunoassay for the serodiagnosis of parasitic infections.

E. Ruitenberg,A. Capron,D. Bout,F. van Knapen

1977-10-01

Abstract:A review of some applications of the Enzyme-Linked Immunosorbent Assay (ELISA) for the serodiagnosis of parasitic infections is presented. Examples are given of applications with trichinellosis, hydatidosis, schistosomiasis, toxoplasmosis, african trypanosomiasis and amoebiasis. ELISA is believed to be a valuable addition to existing serological tools, especially due to its sensitivity and ease of performance.
Polyvinyl Alcohol, a Versatile Excipient for Pharmaceutical 3D Printing

Nadine Couți,Alina Porfire,Rareș Iovanov,Andrea Gabriela Crișan,Sonia Iurian,Tibor Casian,Ioan Tomuță

DOI: https://doi.org/10.3390/polym16040517

IF: 5

2024-02-15

Polymers

Abstract:Three-dimensional (3D) printing in the pharmaceutical field allows rapid manufacturing of a diverse range of pharmaceutical dosage forms, including personalized items. The application of this technology in dosage form manufacturing requires the judicious selection of excipients because the selected materials must be appropriate to the working principle of each technique. Most techniques rely on the use of polymers as the main material. Among the pharmaceutically approved polymers, polyvinyl alcohol (PVA) is one of the most used, especially for fused deposition modeling (FDM) technology. This review summarizes the physical and chemical properties of pharmaceutical-grade PVA and its applications in the manufacturing of dosage forms, with a particular focus on those fabricated through FDM. The work provides evidence on the diversity of dosage forms created using this polymer, highlighting how formulation and processing difficulties may be overcome to get the dosage forms with a suitable design and release profile.

polymer science
Influence of design parameters on sustained drug release properties of 3D-printed theophylline tablets

Thomas Pflieger,Rakesh Venkatesh,Markus Dachtler,Karin Cooke,Stefan Laufer,Dominique Lunter

DOI: https://doi.org/10.1016/j.ijpharm.2024.124207

2024-06-10

Abstract:The application of three-dimensional printing (3DP) in the pharmaceutical industry brings a broad spectrum of benefits to patients by addressing individual needs and improve treatment success. This study investigates the sustained release properties of 3DP tablets containing Theophylline (TPH), which is commonly used to treat respiratory diseases and recently having a comeback due to its potential in the treatment of conditions like Covid-19. Since TPH is a narrow therapeutic window (NTW) drug with serious side effects in the event of overdose, the release properties must be observed particularly closely. We employed a state-of-the-art single screw extrusion 3D printer, which is fed with granules containing the drug. By employing a Taguchi orthogonal array design of experiments (DOE), tablet design parameters and factor related process stability were sought to be evaluated fundamentally. Following this, examinations regarding tailored TPH dosages were undertaken and a relationship between the real printed dose of selected tablet designs and their sustained drug release was established. The release profiles were analyzed using different mathematical model fits and compared in terms of mean dissolution times (MDT). Finally, in-vivo/in-vitro correlation (IVIVC) and physiologically based pharmacokinetic (PBPK) modeling showed that a paradigm patient group could be covered with the dosage forms produced.
Unveiling tablet structural changes: A micro computed tomography analysis of aqueous coating effects

Davide D'Angelo,Eride Quarta,Gianluca Bazzoli,Annalisa Bianchera,Ruggero Bettini

DOI: https://doi.org/10.1016/j.ijpharm.2024.125014

IF: 6.51

2024-12-01

International Journal of Pharmaceutics

Abstract:Tablet coating with aqueous solvents represents a well-established environmentally sustainable alternative to coatings based on organic solvents. However, this practice requires a careful evaluation of potential quality issues, such as increased porosity and crack formation stemming from possible tablet components interaction with water. In this work, a preliminary study on the compression of quaternary mixtures of one model drug and three common excipients was performed to investigate the behaviour of the mixtures and the relevant components during compression. Obtained tablets were coated with a hypromellose aqueous solution followed by an enteric coating with a poly(methyl acrylate-co-methyl methacrylate-co-methacrylic acid) dispersion. At each step, tablet porosity was measured by X-Ray microcomputed tomography (XμCT). XμCT evidenced significant changes in the structure of some tablets upon coating. The mechanical characteristics of the mixture components play a crucial role in the observed porosity increase (up to 12%) after the coating. Materials with remarkable plastic densification upon compression afforded higher structural changes with swelling and cracking formation. XμCT has proven to be an essential technique for identifying morphological changes that could compromise the quality of the tablets.

pharmacology & pharmacy

[Recent studies and acquisitions on microvascular lesions in diabetes mellitus].

Delayed Sustained Drug Release from Electrostatic Powder Coated Tablets with Ultrafine Polymer Blends

Polyvinyl Alcohol-Based 3D Printed Tablets: Novel Insight into the Influence of Polymer Particle Size on Filament Preparation and Drug Release Performance

Study and Characterization of Polyvinyl Alcohol-Based Formulations for 3D Printlets Obtained via Fused Deposition Modeling

Dose-independent drug release from 3D printed oral medicines for patient-specific dosing to improve therapy safety

Production of Bi-Compartmental Tablets by FDM 3D Printing for the Withdrawal of Diazepam

Unraveling the Influence of Solvent Composition on Drop-on-Demand Binder Jet 3D Printed Tablets Containing Calcium Sulfate Hemihydrate

Digital light processing (DLP) 3D printing technique applied in the fabrication of two-layered tablets: The concept of a combined polypill

Impact of immediate release film coating on the disintegration process of tablets

Dosage by design - 3D printing individualized cabozantinib tablets with immediate release

Novel On-Demand 3-Dimensional (3-D) Printed Tablets Using Fill Density as an Effective Release-Controlling Tool

Influence of Polymer Film Thickness on Drug Release from Fluidized Bed Coated Pellets and Intended Process and Product Control

Development of FDM 3D-printed tablets with rapid drug release, high drug-polymer miscibility and reduced printing temperature by applying the acid-base supersolubilization (ABS) principle

Evaluation of Printability of PVA-Based Tablets from Powder and Assessment of Critical Rheological Parameters

The Use of 3D Printed Molds to Cast Tablets with a Designed Disintegration Profile

Fused deposition modeling 3D printing of solid oral dosage forms containing amorphous solid dispersions: How to elucidate drug dissolution mechanisms through surface spectral analysis techniques?

Application of PDMS-based coating in drug delivery systems using PVP as channeling agent

Enzyme immunoassay for the serodiagnosis of parasitic infections.

Polyvinyl Alcohol, a Versatile Excipient for Pharmaceutical 3D Printing

Influence of design parameters on sustained drug release properties of 3D-printed theophylline tablets

Unveiling tablet structural changes: A micro computed tomography analysis of aqueous coating effects